Rapamycin attenuates pyroptosis by suppressing mTOR phosphorylation and promoting autophagy in LPS-induced bronchopulmonary dysplasia

References

• Thébaud B, Goss KN, Laughon M, et al. Bronchopulmonary dysplasia. Nat Rev Dis Primers. 2019;5(1):78. doi:10.1038/s41572-019-0127-7.
   PubMed Web of Science ®Google Scholar
• Gilfillan M, Bhandari A, Bhandari V. Diagnosis and management of bronchopulmonary dysplasia. BMJ. 2021;375:n1974. doi:10.1136/bmj.n1974.
   PubMedGoogle Scholar
• Lui K, Lee SK, Kusuda S, et al. Trends in outcomes for neonates born very preterm and very low birth weight in 11 high-income countries. J Pediatr. 2019;215:32–40.e14. doi:10.1016/j.jpeds.2019.08.020.
   PubMed Web of Science ®Google Scholar
• Stoll BJ, Hansen NI, Bell EF, et al. Trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993–2012. JAMA. 2015;314(10):1039–1051. doi:10.1001/jama.2015.10244.
   PubMed Web of Science ®Google Scholar
• Davidson LM, Berkelhamer SK. Bronchopulmonary dysplasia: chronic lung disease of infancy and long-term pulmonary outcomes. J Clin Med. 2017;6(1):4. doi:10.3390/jcm6010004.
   PubMed Web of Science ®Google Scholar
• Katz TA, Vliegenthart RJS, Aarnoudse-Moens CSH, et al. Severity of bronchopulmonary dysplasia and neurodevelopmental outcome at 2 and 5 years corrected age. J Pediatr. 2022;243:40–46.e2. doi:10.1016/j.jpeds.2021.12.018.
   PubMed Web of Science ®Google Scholar
• Abiramalatha T, Ramaswamy VV, Bandyopadhyay T, et al. Interventions to prevent bronchopulmonary dysplasia in preterm neonates: an umbrella review of systematic reviews and meta-analyses. JAMA Pediatr. 2022;176(5):502–516. doi:10.1001/jamapediatrics.2021.6619.
   PubMed Web of Science ®Google Scholar
• Marc I, Piedboeuf B, Lacaze-Masmonteil T, et al. Effect of maternal docosahexaenoic acid supplementation on bronchopulmonary dysplasia-free survival in breastfed preterm infants: a randomized clinical trial. JAMA. 2020;324(2):157–167. doi:10.1001/jama.2020.8896.
   PubMed Web of Science ®Google Scholar
• Watterberg KL, Walsh MC, Li L, et al. Hydrocortisone to improve survival without bronchopulmonary dysplasia. N Engl J Med. 2022;386(12):1121–1131. doi:10.1056/NEJMoa2114897.
   PubMed Web of Science ®Google Scholar
• Morrow LA, Wagner BD, Ingram DA, et al. Antenatal determinants of bronchopulmonary dysplasia and late respiratory disease in preterm infants. Am J Respir Crit Care Med. 2017;196(3):364–374. doi:10.1164/rccm.201612-2414OC.
   PubMed Web of Science ®Google Scholar
• Taglauer E, Abman SH, Keller RL. Recent advances in antenatal factors predisposing to bronchopulmonary dysplasia. Semin Perinatol. 2018;42(7):413–424. doi:10.1053/j.semperi.2018.09.002.
   PubMed Web of Science ®Google Scholar
• Lapcharoensap W, Gage SC, Kan P, et al. Hospital variation and risk factors for bronchopulmonary dysplasia in a population-based cohort. JAMA Pediatr. 2015;169(2):e143676. doi:10.1001/jamapediatrics.2014.3676.
   PubMed Web of Science ®Google Scholar
• Bergsbaken T, Fink SL, Cookson BT. Pyroptosis: host cell death and inflammation. Nat Rev Microbiol. 2009;7(2):99–109. doi:10.1038/nrmicro2070.
   PubMed Web of Science ®Google Scholar
• Jorgensen I, Miao EA. Pyroptotic cell death defends against intracellular pathogens. Immunol Rev. 2015;265(1):130–142. doi:10.1111/imr.12287.
   PubMed Web of Science ®Google Scholar
• de Gassart A, Martinon F. Pyroptosis: caspase-11 unlocks the gates of death. Immunity. 2015;43(5):835–837. doi:10.1016/j.immuni.2015.10.024.
   PubMed Web of Science ®Google Scholar
• Li D, Li C, Wang T, et al. Geranylgeranyl diphosphate synthase 1 knockdown suppresses NLRP3 inflammasome activity via promoting autophagy in sepsis-induced acute lung injury. Int Immunopharmacol. 2021;100:108106. doi:10.1016/j.intimp.2021.108106.
   PubMed Web of Science ®Google Scholar
• Liao J, Kapadia VS, Brown LS, et al. The NLRP3 inflammasome is critically involved in the development of bronchopulmonary dysplasia. Nat Commun. 2015;6(1):8977. doi:10.1038/ncomms9977.
   PubMedGoogle Scholar
• Peng W, Peng F, Lou Y, et al. Autophagy alleviates mitochondrial DAMP-induced acute lung injury by inhibiting NLRP3 inflammasome. Life Sci. 2021;265:118833. doi:10.1016/j.lfs.2020.118833.
   PubMed Web of Science ®Google Scholar
• Tayman C, Çakır U, Akduman H, Karabulut Ş, Çağlayan M. The therapeutic effect of apocynin against hyperoxy and inflammation-induced lung injury. Int Immunopharmacol. 2021;101(Pt A):108190. doi:10.1016/j.intimp.2021.108190.
   PubMedGoogle Scholar
• Zhao W, Ma L, Cai C, Gong X. Caffeine inhibits NLRP3 inflammasome activation by suppressing MAPK/NF-κB and A2aR signaling in LPS-induced THP-1 macrophages. Int J Biol Sci. 2019;15(8):1571–1581. doi:10.7150/ijbs.34211.
   PubMed Web of Science ®Google Scholar
• Yu L, Chen Y, Tooze SA. Autophagy pathway: cellular and molecular mechanisms. Autophagy. 2018;14(2):207–215. doi:10.1080/15548627.2017.1378838.
   PubMed Web of Science ®Google Scholar
• Biasizzo M, Kopitar-Jerala N. Interplay between NLRP3 inflammasome and autophagy. Front Immunol. 2020;11:591803. doi:10.3389/fimmu.2020.591803.
   PubMed Web of Science ®Google Scholar
• Sun Q, Fan J, Billiar TR, Scott MJ. Inflammasome and autophagy regulation - a two-way street. Mol Med. 2017;23(1):188–195. doi:10.2119/molmed.2017.00077.
   PubMedGoogle Scholar
• Biasizzo M, Trstenjak-Prebanda M, Dolinar K, et al. Cystatin C deficiency increases LPS-induced sepsis and NLRP3 inflammasome activation in mice. Cells. 2021;10(8):2071. doi:10.3390/cells10082071.
   PubMed Web of Science ®Google Scholar
• Ghoneim ME, Abdallah DM, Shebl AM, El-Abhar HS. The interrupted cross-talk of inflammatory and oxidative stress trajectories signifies the effect of artesunate against hepatic ischemia/reperfusion-induced inflammasomopathy. Toxicol Appl Pharmacol. 2020;409:115309. doi:10.1016/j.taap.2020.115309.
   PubMed Web of Science ®Google Scholar
• Cosin-Roger J, Simmen S, Melhem H, et al. Hypoxia ameliorates intestinal inflammation through NLRP3/mTOR downregulation and autophagy activation. Nat Commun. 2017;8(1):98. doi:10.1038/s41467-017-00213-3.
   PubMedGoogle Scholar
• Ip WKE, Hoshi N, Shouval DS, Snapper S, Medzhitov R. Anti-inflammatory effect of IL-10 mediated by metabolic reprogramming of macrophages. Science. 2017;356(6337):513–519. doi:10.1126/science.aal3535.
   PubMed Web of Science ®Google Scholar
• Liu C, Chen Z, Li W, Huang L, Zhang Y. Vitamin D enhances alveolar development in antenatal lipopolysaccharide-treated rats through the suppression of interferon-γ production. Front Immunol. 2017;8:1923. doi:10.3389/fimmu.2017.01923.
   PubMed Web of Science ®Google Scholar
• Zhou O, You J, Xu X, et al. Microvesicles derived from human umbilical cord mesenchymal stem cells enhance alveolar type II cell proliferation and attenuate lung inflammation in a rat model of bronchopulmonary dysplasia. Stem Cells Int. 2022;2022:8465294.
   PubMed Web of Science ®Google Scholar
• Nardiello C, Mižíková I, Morty RE. Looking ahead: where to next for animal models of bronchopulmonary dysplasia? Cell Tissue Res. 2017;367(3):457–468. doi:10.1007/s00441-016-2534-3.
   PubMed Web of Science ®Google Scholar
• Curzer HJ, Perry G, Wallace MC, Perry D. The three Rs of animal research: what they mean for the institutional animal care and use committee and why. Sci Eng Ethics. 2016;22(2):549–565. doi:10.1007/s11948-015-9659-8.
   PubMed Web of Science ®Google Scholar
• Laferriere CA, Pang DS. Review of intraperitoneal injection of sodium pentobarbital as a method of euthanasia in laboratory rodents. J Am Assoc Lab Anim Sci. 2020;59(3):254–263. doi:10.30802/AALAS-JAALAS-19-000081.
   PubMed Web of Science ®Google Scholar
• Collaco JM, McGrath-Morrow SA. Bronchopulmonary dysplasia as a determinant of respiratory outcomes in adult life. Pediatr Pulmonol. 2021;56(11):3464–3471. doi:10.1002/ppul.25301.
   PubMed Web of Science ®Google Scholar
• Charafeddine L, D'Angio CT, Phelps DL. Atypical chronic lung disease patterns in neonates. Pediatrics. 1999;103(4 Pt 1):759–765. doi:10.1542/peds.103.4.759.
   PubMed Web of Science ®Google Scholar
• DeMauro SB. Neurodevelopmental outcomes of infants with bronchopulmonary dysplasia. Pediatr Pulmonol. 2021;56(11):3509–3517. doi:10.1002/ppul.25381.
   PubMed Web of Science ®Google Scholar
• Ahn SY, Chang YS, Lee MH, et al. Stem cells for bronchopulmonary dysplasia in preterm infants: a randomized controlled phase II trial. Stem Cells Transl Med. 2021;10(8):1129–1137. doi:10.1002/sctm.20-0330.
   PubMed Web of Science ®Google Scholar
• Rojas MA, Gonzalez A, Bancalari E, Claure N, Poole C, Silva-Neto G. Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease. J Pediatr. 1995;126(4):605–610. doi:10.1016/s0022-3476(95)70362-4.
   PubMed Web of Science ®Google Scholar
• Liu Y, Hoyo C, Murphy S, et al. DNA methylation at imprint regulatory regions in preterm birth and infection. Am J Obstet Gynecol. 2013;208(5):395.e1–7–395.e7. doi:10.1016/j.ajog.2013.02.006.
   PubMed Web of Science ®Google Scholar
• Thomas W, Speer CP. Chorioamnionitis is essential in the evolution of bronchopulmonary dysplasia – the case in favour. Paediatr Respir Rev. 2014;15(1):49–52. doi:10.1016/j.prrv.2013.09.004.
   PubMed Web of Science ®Google Scholar
• Faro J, Romero R, Schwenkel G, et al. Intra-amniotic inflammation induces preterm birth by activating the NLRP3 inflammasome. Biol Reprod. 2019;100(5):1290–1305. doi:10.1093/biolre/ioy261.
   PubMed Web of Science ®Google Scholar
• Tersigni C, D'Ippolito S, Di Nicuolo F, et al. Recurrent pregnancy loss is associated to leaky gut: a novel pathogenic model of endometrium inflammation? J Transl Med. 2018;16(1):102. doi:10.1186/s12967-018-1482-y.
   PubMedGoogle Scholar
• Qiu X, Cheng X, Zhang J, Yuan C, Zhao M, Yang X. Ethyl pyruvate confers protection against endotoxemia and sepsis by inhibiting caspase-11-dependent cell pyroptosis. Int Immunopharmacol. 2020;78:106016. doi:10.1016/j.intimp.2019.106016.
   PubMed Web of Science ®Google Scholar
• Wu Y, Pan B, Zhang Z, et al. Caspase-4/11-mediated pulmonary artery endothelial cell pyroptosis contributes to pulmonary arterial hypertension. Hypertension. 2022;79(3):536–548. doi:10.1161/HYPERTENSIONAHA.121.17868.
   PubMed Web of Science ®Google Scholar
• Hseu YC, Tseng YF, Pandey S, et al. Coenzyme Q0 inhibits NLRP3 inflammasome activation through mitophagy induction in LPS/ATP-stimulated macrophages. Oxid Med Cell Longev. 2022;2022:4266214–4266215. doi:10.1155/2022/4266214.
   PubMed Web of Science ®Google Scholar
• Turnquist HR, Cardinal J, Macedo C, et al. mTOR and GSK-3 shape the CD4+ T-cell stimulatory and differentiation capacity of myeloid DCs after exposure to LPS. Blood. 2010;115(23):4758–4769. doi:10.1182/blood-2009-10-251488.
   PubMed Web of Science ®Google Scholar
• Lyu W, Li Q, Wang Y, et al. Computational design of binder as the LC3-p62 protein–protein interaction. Bioorg Chem. 2021;115:105241. doi:10.1016/j.bioorg.2021.105241.
   PubMed Web of Science ®Google Scholar
• Salazar G, Cullen A, Huang J, et al. SQSTM1/p62 and PPARGC1A/PGC-1alpha at the interface of autophagy and vascular senescence. Autophagy. 2020;16(6):1092–1110. doi:10.1080/15548627.2019.1659612.
   PubMed Web of Science ®Google Scholar
• Rahman MA, Cho Y, Nam G, Rhim H. Antioxidant compound, oxyresveratrol, inhibits APP production through the AMPK/ULK1/mTOR-mediated autophagy pathway in mouse cortical astrocytes. Antioxidants (Basel). 2021;10(3):408. doi:10.3390/antiox10030408.
   PubMedGoogle Scholar